JSAS HealthCare, Inc.

Public Health

News, Public Health, Treatment & Recovery

JSAS HealthCare Awarded State Funding to Launch Mobile Medication Unit for Opioid Treatment

Neptune, NJ — August 2025 — JSAS HealthCare, Inc. (JSASHC) is proud to announce it has been awarded funding through a competitive Request for Proposal (RFP) process by the New Jersey Department of Human Services, Division of Mental Health and Addiction Services (NJDMHAS) to establish a Mobile Medication Unit (MMU) for Opioid Use Disorder (OUD).

News, Public Health, Treatment & Recovery

Mobile Health Leadership Summit

When it comes to the opioid crisis, collaboration makes all the difference. Join us at the Mobile Health Leadership Summit on August 13-14, 2025, where three industry leaders—including JSAS Healthcare’s Margaret B. Rizzo—will share how they’re driving real change in treatment and recovery. These voices are reshaping how care is delivered, meeting people where they are with compassion, innovation, and action.

Legislation & Advocacy, Public Health

NJATOD Advocates for Reconsideration of MOTAA

The New Jersey Association for the Treatment of Opioid Dependence (NJATOD) expresses strong concerns over the Modernizing Opioid Treatment Access Act (MOTAA), advocating for alignment with recent SAMHSA regulations instead. Highlighting risks such as increased overdoses, NJATOD urges a reconsideration of the act, emphasizing the need for safe and regulated treatment expansion through proven methods like mobile services.

Scroll to Top
Loading...